Institute of Tropical Medicine Antwerp
Foundation of Public Utility

Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial

DSpace/Manakin Repository

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)